BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
MYC
,
Response to oxidative stress
,
Pseudomonas infection
,
Adipose tissue
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PBX
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thyroid gland
Ovary
Vagina
Cervix
Cerebellar hemisphere
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Sepsis due to Streptococcus agalactiae
Systemic infection
Poisoning by drug AND/OR medicinal substance
Pyloric ulcer
Interstitial lung disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
fluticasone
COH29
SB-590885
4'-N-benzoylstaurosporine
roscovitine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR122
SMARCC2
POLH
NOP2
IGFBP2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Wild type and Suz12 mutant LSK or LK mouse bone marrow cells
G9a selectively represses a class of late-replicating genes at the nuclear periphery
Embryonic stem cells and the role of polycomb group genes (SUZ12, RING, EZH2) during differentiation
GABAergic neurons isolated from different brain regions
Whole cerebellums from developing mouse embryos and newborns
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for PBX
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ